Search research articles
Contact Us
Filters
Showing results (21-30 of 150) with videos related to
Page
of 15
Sort By:
Cancer Medicine
|
August 23, 2019
The effects and safety of PD-1/PD-L1 inhibitors on head and neck cancer: A systematic review and meta-analysis
Bi-Cheng Wang, Ru-Bo Cao, Pin-Dong Li, et al.
RNA (New York, N.Y.)
|
May 29, 2010
Single amino acid changes in the predicted RNase H domain of Escherichia coli RNase G lead to complementation of RNase E deletion mutants
Dae-hwan Chung, Zhao Min, Bi-Cheng Wang, et al.
Frontiers in Immunology
|
January 7, 2025
Durvalumab and pembrolizumab in advanced biliary tract cancer: a reconstructed patient-level mimic head-to-head comparative analysis
Bi-Cheng Wang, Bo-Hua Kuang, Guo-He Lin, et al.
Journal of Oncology
|
August 23, 2022
UHRF1 Induces Metastasis in Thyroid Cancer
Bo-Hua Kuang, Guo-He Lin, Quentin Liu, et al.
Annals of Palliative Medicine
|
June 25, 2020
Efficacy and safety of gemcitabine plus capecitabine in the treatment of advanced or metastatic pancreatic cancer: a systematic review and meta-analysis
Bo-Ya Xiao, Bi-Cheng Wang, Guo-He Lin, et al.
Frontiers in Oncology
|
December 9, 2021
Doxorubicin/Adriamycin Monotherapy or Plus Ifosfamide in First-Line Treatment for Advanced Soft Tissue Sarcoma: A Pooled Analysis of Randomized Trials
Bi-Cheng Wang, Bo-Hua Kuang, Bo-Ya Xiao, et al.
Frontiers in Endocrinology
|
July 11, 2024
Emerging chemotherapy-based treatments in anaplastic thyroid cancer: an updated analysis of prospective studies
Bi-Cheng Wang, Guo-He Lin, Bo-Hua Kuang, et al.
Dermatologic Therapy
|
July 13, 2022
The efficacy and safety of cemiplimab in locally advanced or metastatic cutaneous squamous cell carcinoma: A comparative analysis of retrospective studies versus prospective studies
Bi-Cheng Wang, Bo-Ya Xiao, Bo-Hua Kuang, et al.
Translational Cancer Research
|
February 4, 2022
The efficacy and safety of PD-1/PD-L1 inhibitors in breast cancer: a systematic review and meta-analysis
Bo-Ya Xiao, Guo-He Lin, Yan-Xia Zhao, et al.
Plos One
|
October 10, 2022
The efficacy and tolerability of combining pemetrexed-based chemotherapy with gefitinib in the first-line treatment of non-small cell lung cancer with mutated EGFR: A pooled analysis of randomized clinical trials
Bi-Cheng Wang, Wen-Xuan Zhang, Bo-Hua Kuang, et al.
Page
of 15
Search research articles
Search
Showing results (21-30 of 150) with videos related to
Sort By:
Page
of 15
Cancer Medicine
|
August 23, 2019
The effects and safety of PD-1/PD-L1 inhibitors on head and neck cancer: A systematic review and meta-analysis
Bi-Cheng Wang, Ru-Bo Cao, Pin-Dong Li, et al.
RNA (New York, N.Y.)
|
May 29, 2010
Single amino acid changes in the predicted RNase H domain of Escherichia coli RNase G lead to complementation of RNase E deletion mutants
Dae-hwan Chung, Zhao Min, Bi-Cheng Wang, et al.
Frontiers in Immunology
|
January 7, 2025
Durvalumab and pembrolizumab in advanced biliary tract cancer: a reconstructed patient-level mimic head-to-head comparative analysis
Bi-Cheng Wang, Bo-Hua Kuang, Guo-He Lin, et al.
Journal of Oncology
|
August 23, 2022
UHRF1 Induces Metastasis in Thyroid Cancer
Bo-Hua Kuang, Guo-He Lin, Quentin Liu, et al.
Annals of Palliative Medicine
|
June 25, 2020
Efficacy and safety of gemcitabine plus capecitabine in the treatment of advanced or metastatic pancreatic cancer: a systematic review and meta-analysis
Bo-Ya Xiao, Bi-Cheng Wang, Guo-He Lin, et al.
Frontiers in Oncology
|
December 9, 2021
Doxorubicin/Adriamycin Monotherapy or Plus Ifosfamide in First-Line Treatment for Advanced Soft Tissue Sarcoma: A Pooled Analysis of Randomized Trials
Bi-Cheng Wang, Bo-Hua Kuang, Bo-Ya Xiao, et al.
Frontiers in Endocrinology
|
July 11, 2024
Emerging chemotherapy-based treatments in anaplastic thyroid cancer: an updated analysis of prospective studies
Bi-Cheng Wang, Guo-He Lin, Bo-Hua Kuang, et al.
Dermatologic Therapy
|
July 13, 2022
The efficacy and safety of cemiplimab in locally advanced or metastatic cutaneous squamous cell carcinoma: A comparative analysis of retrospective studies versus prospective studies
Bi-Cheng Wang, Bo-Ya Xiao, Bo-Hua Kuang, et al.
Translational Cancer Research
|
February 4, 2022
The efficacy and safety of PD-1/PD-L1 inhibitors in breast cancer: a systematic review and meta-analysis
Bo-Ya Xiao, Guo-He Lin, Yan-Xia Zhao, et al.
Plos One
|
October 10, 2022
The efficacy and tolerability of combining pemetrexed-based chemotherapy with gefitinib in the first-line treatment of non-small cell lung cancer with mutated EGFR: A pooled analysis of randomized clinical trials
Bi-Cheng Wang, Wen-Xuan Zhang, Bo-Hua Kuang, et al.
Page
of 15